NCT01071252 - A Dose Ranging Study of AIN457 in Patients With Moderate to Severe Chronic Plaque-type Psoriasis | Biotech Hunter

Enrollment

125

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions

Chronic Plaque-type Psoriasis

Interventions

DRUG

AIN457

DRUG

Placebo

Trial Locations (19)

1012

Novartis Investigative Site, Riga

10138

Novartis Investigative Site, Tallinn

13419

Novartis Investigative Site, Tallinn

14623

Novartis Investigative Site, Rochester

40217

Novartis Investigative Site, Louisville

51014

Novartis Investigative Site, Tartu

92123

Novartis Investigative Site, San Diego

97035

Novartis Investigative Site, Lake Oswego

97210

Novartis Investigative Site, Portland

B3H 1Z2

Novartis Investigative Site, Halifax

P1B 3Z7

Novartis Investigative Site, North Bay

N2J 1C4

Novartis Investigative Site, Waterloo

IS-201

Novartis Investigative Site, Kopavogur

467-8602

Novartis Investigative Site, Nagoya

371-8511

Novartis Investigative Site, Maebashi

060-0063

Novartis Investigative Site, Sapporo

330-0854

Novartis Investigative Site, Saitama

LV-1001

Novartis Investigative Site, Riga

Unknown

Novartis Investigative Site, Riga